Company Overview

Development Stage

About the Company

[Summary] Leading enterprise in Hubei pharmaceutical industry, one of China's to

Renfu Pharmaceutical Group Co., Ltd. was established in 1993 and listed on the Shanghai Stock Exchange in 1997 (Stock Code: 600079.SH). Renfu Pharmaceutical is the first private high-tech enterprise listed in Hubei Province and also the first listed company in Wuhan East Lake New Technology Development Zone. After nearly 20 years of development, Renfu Pharmaceutical has become a comprehensive pharmaceutical industry group, with nearly 50 pharmaceutical manufacturing, pharmaceutical distribution, health service, and medical enterprises under its umbrella. It is the leading enterprise in Hubei Province with the strongest production capacity, the most complete dosage forms, the broadest product range, and the most abundant resources, and is one of the most investment-worthy listed pharmaceutical companies in the capital market.
As a "National Enterprise Technology Center" and "Unit Undertaking National Major New Drug Creation Special Projects," the company adheres to a R&D-first approach, continuously investing in research and development, establishing close ties and cooperation platforms with renowned domestic and international research institutions, and collaborating with the Chinese Academy of Military Medical Sciences to establish the "JUNKE Guanggu Innovative Drug R&D Center."
Renfu Pharmaceutical adheres to the strategy of being a "market leader in niche segments" within the pharmaceutical field, having established leadership in areas such as anesthetics, reproductive regulation drugs, and Uyghur medicine domestically, while also cultivating its unique competitiveness in multiple niche fields including biological products and genetic engineering drugs. Simultaneously, it aims to build a leading regional pharmaceutical distribution enterprise, achieving healthy interaction between manufacturing and distribution. Renfu Pharmaceutical is actively integrating into the international market, striving to become a globally operating pharmaceutical company.
Renfu Pharmaceutical's goal is to achieve annual sales revenue exceeding 30 billion yuan during the 13th Five-Year Plan period, enter the top 10 in China's pharmaceutical industry, and become one of the leaders in China's pharmaceutical sector!

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

Renfu Pharmaceutical Financing History (1 rounds)

Manage
IPO上市
Capital Market Favor
Latest Financing Round
  • Date: ?
  • Market: 主板
  • Deal: 上交所

Renfu Pharmaceutical How Fast Is Hiring Growing? (131 open positions)

Manage
Note: How fast is hiring at Renfu Pharmaceutical Group Co., Ltd. growing? Renfu Pharmaceutical2025: 167 openings (up 169%), 2024: 62 openings (up 9%), 2023: 57 openings (up 58%), 2022: 36 openings (down 66%), 2021: 105 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

Renfu Pharmaceutical Master's Degree Job Demand Analysis

(More)
How fast is master's hiring at Renfu Pharmaceutical Group Co., Ltd. growing? Renfu PharmaceuticalMaster's recruitment over the years: 2025: 22 openings (up 100%), 2024: 11 openings (down 21%), 2023: 14 openings (up 17%), 2022: 12 openings (up 100%), 2021: 6 openings.

Renfu Pharmaceutical Doctoral Degree Job Demand Analysis

(More)
+8%
Growth Rate
2026 vs 2025
  • 2025: Up 550%
  • 2024: Down 71%
  • 2023: Up 75%
  • 2022: Up 300%
Renfu Pharmaceutical Doctoral Hiring by Year: 2026 — 1 more jobs than 2025
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is doctoral hiring at Renfu Pharmaceutical Group Co., Ltd. growing? Renfu PharmaceuticalDoctorate recruitment over the years: 2026: 14 openings (up 8%), 2025: 13 openings (up 550%), 2024: 2 openings (down 71%), 2023: 7 openings (up 75%), 2022: 4 openings (up 300%), 2021: 1 openings.

Renfu Pharmaceutical R&D Strength (Technical Talent Demand)

(More)
How is the demand for technical talent at Renfu Pharmaceutical Group Co., Ltd.? Based on an analysis of Renfu Pharmaceutical's job postings over the past year, "医疗卫生/美容保健类" demand: 30.6%, "计算机/网络/技术类": 26.2%, "生物/制药/化工/环保类": 10.6%, "其他(研发和技术类)": 3.5%, "科研类": 2.9%, "电气/能源/动力类": 1.5%. For reference only.

Renfu Pharmaceutical — What Are the Salaries Like? (340 records)

Manage
Renfu Pharmaceutical Salary Overview
salary range: 6K - 50K, 76.5% of roles pay ¥10-20K
Note: salary statistics are based on 340 salary records from the past year and depend on the job sample. For reference only.
How is the salary at Renfu Pharmaceutical Group Co., Ltd.?Renfu Pharmaceutical76.5% of positions earn 10-20K, Undergraduate salary: ¥。Wuhan salary ranking: #580,销售类 average salary ¥13.1K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of Renfu Pharmaceutical

(More)
Are salaries high at Renfu Pharmaceutical Group Co., Ltd.? We provide: 医药代表,信息,临床,研究员,医学经理,pv,药物警戒,车间,cad,ra,合规,并购,qa,产品经理,党建,化学,培训,市场,推广,数据统计. Click to view detailed salary analysis by job.

Renfu Pharmaceutical — Fortune 500? (More)

Renfu Pharmaceutical Related Industry Tags

Job Category

  • 销售类
    67.2% of total 67.2%
  • 医疗卫生/美容保健类
    30.5% of total 30.5%
  • 计算机/网络/技术类
    26.1% of total 26.1%
  • 经营管理类
    11.8% of total 11.8%

Education

  • 本科
    44.3% of total 44.3%
  • 大专
    37.4% of total 37.4%
  • 硕士
    13.2% of total 13.2%
  • 博士
    4.3% of total 4.3%

Experience

  • 1-3年
    68.4% of total 68.4%
  • 5-10年
    14.9% of total 14.9%
  • 3-5年
    9.2% of total 9.2%
  • 不限
    7.5% of total 7.5%
View Detailed Analysis

What does Renfu Pharmaceutical Group Co., Ltd. require? Who is Renfu Pharmaceutical hiring? Renfu Pharmaceutical recruitment: 销售类占比最多占67.2%,其次是医疗卫生/美容保健类占30.5%. What education can get in at Renfu Pharmaceutical? 本科占比最多占44.3%,其次是大专占37.4%. High education required at Renfu Pharmaceutical? 硕士占13.2%,博士占4.3%. Work experience required at Renfu Pharmaceutical? 1-3年占比最多占68.4%,其次是5-10年占14.9%. Where are the job locations at Renfu Pharmaceutical? 武汉占比最多占35.3%,其次是上海占4%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 163,222.5965万(元)
Legal Representative: 杜文涛
Date Established:
Credit Code: 914201003000148505
Registered Address: 武汉东湖高新区高新大道666号

Partners & Suppliers

国药股份采购人福的麻精药品及生育调节药品用于分销 Source
合作客户 化学药品(国内仿制药企)
提供麻醉及精神类药物药学研究 Source
供应商 化学药研发企业
科贝科技为其提供实验室装备 Source
供应商 生物医药
湖北得乐康向人福医药提供生物酶催化技术服务,用于原料药合成 Source
供应商 医药研发合作
向人福医药供应抗肿瘤原料药 Source
供应商 原料药客户

People who follow Renfu Pharmaceutical also follow

Renfu Pharmaceutical Competitors (Similar Companies)

制药/药业 原料药 麻醉药 医药
“A large private modern pharmaceutical distribution enterprise in China”
新药研发 医药工业 麻醉药 试剂
“A technology-driven international pharmaceutical enterprise”
“Top 30 enterprise in China's pharmaceutical industry”
“Trustworthy biological experiment service provider”
“Committed to providing green, safe, affordable and abundant biopharmac”
“Providing antibody drug R&D and production contract services for inter”
“A high-tech enterprise integrating pharmaceutical production, R&D, and”
“It is a large high-tech enterprise integrating production, education, ”
“Writing memories with chips, letting the world's beauty last forever”
“Dedicated to animal health technology to enhance life quality”
“成为中国医药研发CRO旗舰企业”
“To become a global enterprise trusted and loved by the public”
生殖健康 生产 药物制剂 优生优育

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates